Sunshine Biopharma (SBFM) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.5
-1.7
-0.91
-0.11

Details

Expected EPS
-2.5
Actual EPS
-2.5
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Sunshine Biopharma⁩ (⁦SBFM⁩) has reported earnings of ⁦-2.5⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts